C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof

Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
12/2002
12/12/2002	US20020187126 Using modified herpes simplex virus (HSV) having a defect in ICP27 (HSV Delta 27), wherein the cancer cell is resistant to anti-cancer therapy.
12/12/2002	US20020187125 Reovirus for the treatment of neoplasia
12/12/2002	US20020187068 Method of inactivating pathogens
12/12/2002	CA2448444A1 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes
12/12/2002	CA2448066A1 Chimeric alphavirus replicon particles
12/11/2002	EP1264892A2 Lentiviral vectors comprising endothelial cell specific promoters
12/11/2002	EP1263986A1 Platform for the discovery of the bacterial genes involved in rna modification
12/11/2002	EP1263965A2 Avirulent, immunogenic flavivirus chimeras
12/11/2002	EP1263964A2 Recombinant hhv8 dna
12/11/2002	EP1263936A1 Altered strain of the modified vaccinia virus ankara (mva)
12/11/2002	EP1263474A1 A method of sensitising endothelial cells to prodrugs
12/11/2002	EP0835131B1 cDNA CLONE FOR SOUTH AFRICAN ARBOVIRUS NO. 86
12/11/2002	EP0713397B1 Vaccine containing live virus
12/11/2002	EP0591431B1 Hepatitis c virus (hcv) polypeptides
12/11/2002	CN1384885A Prep. of recombinant adenoviruses and adenovirus banks
12/11/2002	CN1384884A Herpes virus vectors for dendritic cells
12/11/2002	CN1384883A Production of recombinant respiratory syncytical viruses expressing immune modulatory molecules
12/11/2002	CN1384877A Rescue of mumps virus from cDNA
12/11/2002	CN1384876A Modular transport systems for molecular substances and production and use thereof
12/11/2002	CN1384199A Recombinant expression vector expressing human pancreatic tissue kallikrein gene and prepn of human pancreatic tissue kallikrein
12/10/2002	USRE37933 Locally administering to mammalian vascular smooth muscle cells replication defective recombinant adenovirus comprising gene encoding mammalian gax protein, wherein gene is expressed and proliferation of cells is inhibited
12/10/2002	US6492343 Porcine adenovirus type 3 genome
12/10/2002	US6492169 Complementing cell lines
12/10/2002	US6492165 Retrovirus isolated from humans
12/10/2002	US6492161 Bacteriophage RM 378 of a thermophilic host organism
12/10/2002	US6492160 Methods for producing members of specific binding pairs
12/10/2002	US6492148 A method for the preparation of an infectious ibdv mutant which will replicate in cef cell culture, comprising: separately preparing a dna construct comprising cdna of genome segments a and b of an ibdv which is not capable of
12/10/2002	US6492105 Binding molecules for human factor VIII and factor VIII-like proteins
12/10/2002	US6491907 Genetic engineered chimera particles comprising capsids from adeno-associated virus and genome inverted terminal repeat sequences as vectors for supplying and expressing nucleotide sequence in cells
12/10/2002	CA2047290C Recombinant marek's disease virus
12/05/2002	WO2002097104A1 Pseudotyping vih-1 vectors with the aid of rhabdovirus envelopes
12/05/2002	WO2002097072A2 Influenza vaccine composition
12/05/2002	WO2002097056A2 Method for generating replication defective viral vectors that are helper free
12/05/2002	WO2002097034A2 Antibodies and antigens of hiv viremia controllers
12/05/2002	WO2002096940A2 Attenuated very virulent infectious bursal disease virus
12/05/2002	WO2002096939A2 Adenovirus protein ix, its domains involved in capsid assembly, transcriptional activity and nuclear reorganization
12/05/2002	WO2002064757A3 Influenza viruses with enhanced transcriptional and replicational capacities
12/05/2002	WO2002060924A9 Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding and development of a non-simian recombinant cell line for propagation of the virus and a target for a novel class of antiviral compounds
12/05/2002	WO2002028351A9 Recombinant mucin binding proteins from steptococcus pneumoniae
12/05/2002	US20020184661 Dna shuffling to produce nucleic acids for mycotoxin detoxification
12/05/2002	US20020183247 Lipoparticle comprising a protein and methods of making and using the same
12/05/2002	US20020182733 Vector and methods of use for selective expression of genes in sites of angiogenesis in vivo
12/05/2002	US20020182724 Expression vector for use tools in genome analysis and generation of transgenic animals
12/05/2002	US20020182723 Generation of genetically engineered viral vectors; obtain cells, infect with genetically engineered vector, propagate and harvest viral vectors
12/05/2002	US20020182581 Treating blood or blood products with compounds which have a mustard, aziridinium or aziridine group and a nucleic acid binding group
12/05/2002	US20020182228 Methods for producing self-replicating infectious RSV particles comprising recombinant RSV genomes or antigenomes and the N, P, L, and M2 proteins
12/05/2002	US20020182182 Recombinant viral vector encoding a human very low density lipoprotein (VLDL) receptor, operatively linked to regulatory sequences directing expression in a hepatocyte; familial hypercholesterolemia or hyperlipidemia
12/05/2002	US20020182107 Rapid sterilization and vaccine preparation
12/05/2002	DE10114209A1 Ortsgerichtete Transformation durch Verwendung von Amplifikationsvektoren Site-directed transformation by using amplification vectors
12/04/2002	EP1262554A2 Defective packaging non-oncoviral vectors based on mpmv and hiv
12/04/2002	EP1261734A1 GENOMIC ANALYSIS OF tRNA GENE SETS
12/04/2002	EP1261701A2 FULL-LENGTH INFECTIOUS cDNA CLONES OF TICK BORNE FLAVIVIRUS
12/04/2002	EP1261699A1 Protecting molecules in biologically derived compositions while treating with broad-spectrum pulsed light
12/04/2002	EP1261693A2 Hyperthermia and immunotherapy for leukemias, lymphomas, and solid tumors
12/04/2002	EP1261645A1 Anti-viral conjugate comprising a factor allowing the translocation of a protein across a cell membrane and comprising a single-chain antibody fragment directed against a viral protein
12/04/2002	EP1261629A2 Rotavirus pseudoviral particles and use thereof for vectorizing proteins or nucleic acids
12/04/2002	EP0690915B1 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof
12/03/2002	US6489448 Antibody to a protein with thiol specific antioxidant (tsa) activity; vaccines
12/03/2002	US6489167 Retroviral packaging cassettes amplified in the cytoplasm by autocatalytic Togavirus vectors
12/03/2002	US6489162 A cell line permissive for adeno-associated virus replication stably transformed with helper adeno-associated virus dna which lacks adeno-associated virus terminal repeat sequences and contains adenovirus terminal repeat sequences
12/03/2002	US6489144 Culturing cells that overproduce double-stranded-rna-dependent kinase and treatment with inducer
12/03/2002	US6489142 Genes for retrovirus incorporated in recombined adenovirus defective for e1 or e4 regions
12/03/2002	US6489141 Codon replacement for higher translational efficiency
11/2002
11/28/2002	WO2002095075A1 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
11/28/2002	WO2002095040A1 Delections in arterivirus replicons
11/28/2002	WO2002095023A2 Replicons derived from positive strand rna virus genomes useful for the production of heterologous proteins
11/28/2002	WO2002095017A1 Novel mixed lineage kinase (7) (mlk7) polypeptide, polynucleotides encoding the same, and methods of use thereof
11/28/2002	WO2002094997A2 Transcriptional regulation of target genes
11/28/2002	WO2002094879A1 Antibodies specific for cd44v6
11/28/2002	WO2002094878A1 Hevein-binding monoclonal antibodies
11/28/2002	WO2002050304A3 Oncolytic virus
11/28/2002	WO2002038782A3 Viral expression system
11/28/2002	US20020177230 Generating genetically engineered viral genome; obtain clones, incubate with restriction enzymes, recover nucleotide sequence, ligate and generate viral genome
11/28/2002	US20020177222 Replication competent AAV helper functions
11/28/2002	US20020177216 Culturing preferential mammalian virus; obtain mammalian cells, infect cell with virus, culture cells and recover viral particles
11/28/2002	US20020177215 Methods for producing purified adenoviral vectors
11/28/2002	US20020177128 Variant of LAV viruses
11/28/2002	US20020176870 Methods and compositions useful for stimulating an immune response
11/28/2002	US20020176869 Hepatitus A virus vaccines
11/28/2002	CA2755964A1 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
11/28/2002	CA2448102A1 Novel mixed lineage kinase (7) (mlk7) polypeptide, polynucleotides encoding the same, and methods of use thereof
11/28/2002	CA2447680A1 Hevein-binding monoclonal antibodies
11/28/2002	CA2443437A1 Antibodies specific for cd44v6
11/28/2002	CA2443258A1 Replicons derived from positive strand rna virus genomes useful for the production of heterologous proteins
11/27/2002	EP1260581A1 Cell usable in serum-free culture and suspension culture and process for producing virus for vaccine by using the cell
11/27/2002	EP1259629A2 Recombinant influenza a viruses
11/27/2002	EP1259606A2 Compositions useful for regulating parkin gene activity
11/27/2002	EP1259605A2 Mutated cyclin g1 protein
11/27/2002	EP1259601A2 Chimeric and tcr phage display libraries, chimeric and tcr reagents and methods of use thereof
11/27/2002	EP1259258A1 Gm-negative ehv-mutants
11/27/2002	EP1259256A1 Antigenic complexes and methods
11/27/2002	EP0630409B1 Defective packaging non-oncoviral vectors based on mpmv
11/27/2002	EP0585267B1 Herpesvirus particle preparation and vaccine
11/27/2002	CN1381563A Recombinant adenovirus expressing human rotavirus VP7 and its preparing process and usage
11/27/2002	CN1094974C Recombined adhenovirus expressing human interleukin 12 and its preparation and use
11/27/2002	CN1094973C Recombined adhenovirus expressing human interleukin 18 and its preparation and use
11/26/2002	US6485966 Hybrid microorganism for use in gene therapy
11/26/2002	US6485965 Replicating or semi-replicating viral constructs, preparation and uses for gene delivery
11/26/2002	US6485958 Method for producing recombinant adenovirus
11/26/2002	US6485940 Broad spectrum infectious bursal disease virus vaccine

1 ... 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 ... 267